Treatment Response Classes in Major Depressive Disorder Identified by Model-Based Clustering and Validated by Clinical Prediction Models

Translational Psychiatry - United Kingdom
doi 10.1038/s41398-019-0524-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gene Expression Biomarkers of Response to Citalopram Treatment in Major Depressive Disorder

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2011English

Treatment-Resistant Major Depressive Disorder and Assisted Dying

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2015English

Duloxetine in the Treatment of Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2002English

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Third-Wave Cognitive Therapy Versus Mentalisation-Based Treatment for Major Depressive Disorder: A Randomised Clinical Trial

BMJ Open
Medicine
2014English

Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder

American Journal of Psychiatry
PsychiatryMental Health
2010English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder

Expert Opinion on Drug Discovery
Drug Discovery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy